Form 4 Tracker
NEUROCRINE BIOSCIENCES INC
NBIX

71 insider filings · Latest: Sep 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 14, 2026Sep 15 9:03 PMDavid W. BoyerChief Corp. Affairs Officer
Sale
826$157.45$130.1K8,722(D)

View →

Sep 14, 2026Sep 15 9:02 PMMatt AbernethyChief Financial Officer
Sale
2,311$157.20$363.3K42,808(D)

View →

Sep 14, 2026Sep 14 8:49 PMMATTHEW C ABERNETHY
Proposed Sale
2,311$156.22$361.0K—

View →

Sep 14, 2026Sep 14 8:39 PMDAVID WARREN BOYER
Proposed Sale
4,714$156.22$736.4K—

View →

Sep 9, 2026Sep 11 12:29 AMEric BenevichChief Commercial Officer
Sale
2,154$154.61$333.0K64,408(D)

View →

Sep 9, 2026Sep 9 8:19 PMERIC BENEVICH
Proposed Sale
2,154$155.13$334.2K—

View →

Jul 28, 2026Jul 30 9:29 PMLeslie V NorwalkDirector
Sale
1,250$182.01$227.5K1,588(D)

View →

Jul 10, 2026Jul 13 8:27 PMIngrid DelaetChief Regulatory Officer
Sale
4,367$181.02$790.5K16,225(D)

View →

Jul 9, 2026Jul 13 8:27 PMDarin LippoldtChief Legal Officer
Sale
10,000$179.60$1.8M54,729(D)

View →

Jul 10, 2026Jul 10 8:39 PMINGRID DELAET
Proposed Sale
4,367$180.55$788.5K—

View →

Jul 9, 2026Jul 9 10:41 PMIngrid DelaetChief Regulatory Officer
Sale
8,433$178.72$1.5M16,225(D)

View →

Jul 8, 2026Jul 9 10:41 PMIngrid DelaetChief Regulatory Officer
Sale
2,737$178.54$488.7K16,225(D)

View →

Jul 7, 2026Jul 9 10:41 PMIngrid DelaetChief Regulatory Officer
Sale
3,401$178.57$607.3K16,225(D)

View →

Jul 9, 2026Jul 9 8:27 PMDARIN LIPPOLDT
Proposed Sale
10,000$178.24$1.8M—

View →

Jul 7, 2026Jul 7 8:33 PMINGRID DELAET
Proposed Sale
14,571$174.10$2.5M—

View →

Jun 29, 2026Jun 30 8:52 PMDarin LippoldtChief Legal Officer
Sale
9,800$170.16$1.7M54,729(D)

View →

Jun 26, 2026Jun 30 8:52 PMDarin LippoldtChief Legal Officer
Sale
200$169.57$33.9K54,729(D)

View →

Jun 29, 2026Jun 29 8:43 PMDARIN LIPPOLDT
Proposed Sale
9,800$168.52$1.7M—

View →

Jun 26, 2026Jun 26 8:25 PMDARIN LIPPOLDT
Proposed Sale
200$164.18$32.8K—

View →

Jun 5, 2026Jun 9 9:40 PMSHERWIN STEPHEN ADirector
Sale
25,000$165.32$4.1M15,860(D)

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 27, 2026May 29 10:03 PMShalini SharpDirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:03 PMSHERWIN STEPHEN ADirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:02 PMMORROW GEORGE JDirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:02 PMWilliam H RastetterDirector
Grant/Award
2,567$0.002,567(D)

View →

May 27, 2026May 29 10:01 PMLeslie V NorwalkDirector
Grant/Award
3,908$155.832,624(D)

View →

May 21, 2026May 21 11:24 PMSHERWIN STEPHEN ADirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:24 PMShalini SharpDirector
Option Exercise
1,659—0(D)

View →

May 21, 2026May 21 11:24 PMWilliam H RastetterDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:23 PMPOPS RICHARD FDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:22 PMChristine A PoonDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:22 PMLeslie V NorwalkDirector
Option Exercise
1,659—0(D)

View →

May 21, 2026May 21 11:21 PMMORROW GEORGE JDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:21 PMJohanna MercierDirector
Option Exercise
3,318—0(D)

View →

May 21, 2026May 21 11:21 PMLYONS GARY ADirector
Option Exercise
1,659—0(D)

View →

May 19, 2026May 21 9:49 PMKevin Charles GormanDirector
Option Exercise
205,088$43.240(D)

View →

May 15, 2026May 18 9:50 PMPOPS RICHARD FDirector
Option Exercise
15,000$47.890(D)

View →

Feb 13, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Option Exercise
4,807—2,566(D)

View →

Feb 13, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Grant/Award
51,830$124.127,735(D)

View →

Feb 12, 2026Feb 17 10:49 PMMatt AbernethyChief Financial Officer
Option Exercise
2,133—6,401(D)

View →

Feb 13, 2026Feb 17 10:48 PMDavid W. BoyerChief Corp. Affairs Officer
Option Exercise
3,352—1,812(D)

View →